Literature DB >> 8786325

Neutrophil lactoferrin release induced by IgA immune complexes can be mediated either by Fc alpha receptors or by complement receptors through different pathways.

W Zhang1, P J Lachmann.   

Abstract

Our previous results showed that neutrophil secondary granule release, indicated by release of lactoferrin, was a slow process when induced by IgA immune complexes (IC) formed in heat-inactivated serum, but became very fast if IgA IC were formed in normal human serum. This phenomenon did not apply to the IC of other Ab isotypes. In this paper, we demonstrate that the fast lactoferrin release is caused by complement, mainly due to the deposition of C3b and iC3b on IgA IC. Either CR1 or CR3 can mediate the response and both receptors have to be blocked to prevent it. Complement also influences FcalphaR-mediated lactoferrin release, in that this is enhanced by the anaphylatoxin peptides, C5a and C5a(desArg). Divalent cations are required for FcalphaR and CR3- but not for CR1-mediated lactoferrin release. Genistein, a protein tyrosine kinase inhibitor, totally inhibits FcalphaR-mediated response, but has little effect on CR1-mediated response. Therefore, it is clear that different pathways of intracellular signaling are utilized. In addition, stimulation through FcalphaR promotes the receptor up-regulation, which is abolished by the presence of EDTA or genistein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786325

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross-linking of fcalpha receptors (FcalphaR) with a monoclonal antibody, MIP8a.

Authors:  W Zhang; B Bi; R G Oldroyd; P J Lachmann
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

2.  Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).

Authors:  Robert J Boackle; Quang L Nguyen; Renata S Leite; Xiaofeng Yang; Jana Vesely
Journal:  Mol Immunol       Date:  2005-03-05       Impact factor: 4.407

3.  Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.

Authors:  K Olas; H Butterweck; W Teschner; H P Schwarz; B Reipert
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

4.  Improved ex vivo blood compatibility of central venous catheter with noble metal alloy coating.

Authors:  Manijeh Vafa Homann; Dorota Johansson; Håkan Wallen; Javier Sanchez
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2015-07-06       Impact factor: 3.368

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.